Composition

100 ml of preparation contains active substance Enrofloxacin – 10.0 g; Additional ingredients.

Pharmacological properties

Enrofloxacin is a chemotherapeuti preparati belonging to the group of fluoroquinolones (derivative quinolone-carboxylic acid). Enrofloxacin shows anti obial acti by inhibiti the enzyme acti of DNA gyrase, which is a major catalyst for the replicati of DNA in a bacterial cell. Inhibiti of DNA gyrase acti leads to functi disorders, blocking the biosynthesis in the cell and destructi of the pathogen. The result is a rapid bactericidal effect. Enrofloxacin is effecti e against different types of microorganisms: Mycoplasma spp., E. coli, Salmonella spp., Campylobacter spp., Haemophilus spp., Pasteurella spp., Bordetella spp., Klebsiella spp., Streptococcus spp., Enterococcus spp., Erysipelothrix rhusiopathiae, Proteus spp., Vibrio parahaemolyti Staphylococcus aureus.

Administration

Treatment of bovine, sheep, goats with respiratory and digestive tract diseases, caused by microorganisms susception to Enrofloxacin.

Swine: treatment of animals with MMA syndrome and in case of the respiratory and digesti e tract diseases caused by microorganisms suscepti to Enrofloxacin.

Routes of administration and dosages

If dose volume exceeds 5 ml for audult cattle and 2.5 ml for cattle youngsters and swine it should be devided and administered into different injection sites.

Withdrawal period

Meat – in 7 days after the last treatment. Milk for human consumpti is allowed in 4 days after the last treatment. Meat and milk received before this period should be disposed or fed to non-producti e animals, depending on conclusion of veterinarian.

Self life

24 months. After first opening – 14 days if kept in dark place at +5 to +25° С.

Storage conditions

Store in dry, dark places, out of the reach of children, at +5 to +25° С.